Paysign, Inc. (NASDAQ:PAYS – Get Free Report) insider Matthew Louis Lanford sold 25,360 shares of Paysign stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $3.96, for a total value of $100,425.60. Following the transaction, the insider now owns 109,731 shares in the company, valued at approximately $434,534.76. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.
Paysign Stock Performance
Shares of NASDAQ:PAYS traded down $0.17 during trading hours on Wednesday, reaching $3.68. The stock had a trading volume of 134,817 shares, compared to its average volume of 251,627. The firm’s 50 day moving average is $3.96 and its 200-day moving average is $4.34. Paysign, Inc. has a 1 year low of $2.22 and a 1 year high of $5.59. The stock has a market capitalization of $197.06 million, a price-to-earnings ratio of 25.60 and a beta of 0.95.
Paysign (NASDAQ:PAYS – Get Free Report) last posted its earnings results on Tuesday, November 5th. The company reported $0.03 EPS for the quarter, topping the consensus estimate of $0.01 by $0.02. The firm had revenue of $15.26 million during the quarter, compared to analysts’ expectations of $14.96 million. Paysign had a net margin of 14.28% and a return on equity of 30.64%. During the same quarter in the prior year, the firm earned $0.02 EPS. Analysts forecast that Paysign, Inc. will post 0.21 EPS for the current year.
Institutional Investors Weigh In On Paysign
Analysts Set New Price Targets
Separately, Barrington Research restated an “outperform” rating and set a $7.00 target price on shares of Paysign in a research report on Monday, November 4th.
View Our Latest Analysis on PAYS
About Paysign
Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.
Further Reading
- Five stocks we like better than Paysign
- What is an Earnings Surprise?
- Rocket Lab is the Right Stock for the Right Time
- What is the Hang Seng index?
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- How to Choose Top Rated Stocks
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Paysign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paysign and related companies with MarketBeat.com's FREE daily email newsletter.